Meningioma Overview

Save information for later
Sign Up

Learn About Meningioma

View Main Condition: Brain Tumor

What is the definition of Meningioma?
Meningiomas are tumors that originate in the meninges, the membranes that surround the brain and spinal cord. Most Meningiomas are not cancerous (benign), though a minority of Meningiomas can be classified as atypical or cancerous (malignant). Though rare, malignant Meningiomas can be highly aggressive. However, even benign Meningiomas can cause problems if their growth affects neighboring areas of the brain. Though most Meningiomas grow slowly, there is no way to predict the rate of growth for a particular Meningioma or to know how long a specific Meningioma was growing before it was diagnosed. Signs and symptoms can vary but may include seizures, headaches, weakness in the arms and legs, and vision loss. Sometimes memory loss, carelessness, and unsteadiness are the only symptoms.
What are the alternative names for Meningioma?
  • Meningioma
Who are the top Meningioma Local Doctors?
Elite in Meningioma
Dr. James J. Evans
Neurosurgery
Elite in Meningioma
Dr. James J. Evans
Neurosurgery

Jefferson University Physicians

925 Chestnut St, 
Philadelphia, PA 
215-955-8874
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

James Evans is a Neurosurgery provider in Philadelphia, Pennsylvania. Dr. Evans and is rated as an Elite provider by MediFind in the treatment of Meningioma. His top areas of expertise are Cerebrospinal Fluid Leak, Pituitary Tumor, Meningioma, Endoscopic Transnasal Transsphenoidal Surgery, and Septoplasty. Dr. Evans is currently accepting new patients.

Elite in Meningioma
Dr. Christopher J. Farrell
Neurosurgery
Elite in Meningioma
Dr. Christopher J. Farrell
Neurosurgery

Jefferson University Physicians

111 S 11th St, 
Philadelphia, PA 
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Christopher Farrell is a Neurosurgery provider in Philadelphia, Pennsylvania. Dr. Farrell and is rated as an Elite provider by MediFind in the treatment of Meningioma. His top areas of expertise are Meningioma, Pituitary Tumor, Astrocytoma, Endoscopic Transnasal Transsphenoidal Surgery, and Awake Craniotomy.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Meningioma
Dr. Douglas S. Kondziolka
Neurosurgery
Elite in Meningioma
Dr. Douglas S. Kondziolka
Neurosurgery

New York University

111 Broadway, Fl 2, 
New York, NY 
212-263-9701
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Douglas Kondziolka is a Neurosurgery provider in New York, New York. Dr. Kondziolka and is rated as an Elite provider by MediFind in the treatment of Meningioma. His top areas of expertise are Schwannoma, Acoustic Neuroma, Arteriovenous Malformation, Gamma Knife Radiosurgery, and Endovascular Embolization.

View All Doctors
What are the latest Meningioma Clinical Trials?
Phase I/II Study of Lutathera in Patients With Recurrent and/or Progressive High-Grade Central Nervous System Tumors and Meningiomas That Demonstrate Uptake on DOTATATE PET
Phase I/II Study of Lutathera in Patients With Recurrent and/or Progressive High-Grade Central Nervous System Tumors and Meningiomas That Demonstrate Uptake on DOTATATE PET
Who is this study for: Patients with Malignant Glioma, Embryonal Tumor
Enrollment Status: Recruiting
Publish Date: June 11, 2025
Intervention Type: Drug
Study Drug: LUTATHERA® (Lutetium Lu 177 Dotatate)
Study Phase: Phase 1/Phase 2

Summary: This study will evaluate the safety and efficacy of Lutathera (177Lu-DOTATATE) in patients with progressive or recurrent High-Grade Central Nervous System (CNS) tumors and meningiomas that demonstrate uptake on DOTATATE PET. The drug will be given intravenously once every 8 weeks for a total of up to 4 doses over 8 months in patients aged 4 to \<12 years (Phase I) or 12 to \

Match to trials
Find the right clinical trials for you in under a minute
Get started
Therapeutic Endovascular Embolization for Intracranial Meningioma
Therapeutic Endovascular Embolization for Intracranial Meningioma
Enrollment Status: Recruiting
Publish Date: June 05, 2025
Intervention Type: Procedure
Study Phase: Not Applicable

Summary: The natural course for meningioma suggests that a majority will grow over time. Treatment is usually indicated in growing or symptomatic meningiomas. Surgery is usually primary treatment, but there is a significant risk of adverse effects. Stereotactic radiotherapy is most often reserved to treat relapses after surgery, and except for surgery and radiotherapy there are no other established treatme...

View All Clinical Trials
Who are the sources who wrote this article ?

Published Date: May 11, 2022
Published By: Genetic and Rare Diseases Informnation Center